Amgen unveils its KRas inhibitor in human clinical trials
Tuesday, May 28, 2019 - 21:10
in Health & Medicine
AMG 510 shuts down a mutant version of the cancer target via covalent interaction
Updated by artificial intelligence Sat, 3 Jan 2026, 15:40:35 UTC Learn more
- Tell your friends
- Get science news via